Search research articles
Contact Us
Filters
Showing results (151-160 of 160) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 160 results.
Nucleic Acids Research
|
July 25, 2000
The mouse L-histidine decarboxylase gene: structure and transcriptional regulation by CpG methylation in the promoter region
S Suzuki-Ishigaki, K Numayama-Tsuruta, A Kuramasu, et al.
Acta Paediatrica Japonica : Overseas Edition
|
August 8, 1998
Evaluation of left ventricular volume using automatic border detection in children: a comparison with conventional off-line echocardiographic quantification
I Hashimoto, F Ichida, M Miura, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters
S Ebara, S Shimura, Y Nasu, et al.
Clinical and Experimental Immunology
|
December 22, 1999
Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders
T Wada, K Takei, M Kudo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter
C Pramudji, S Shimura, S Ebara, et al.
Chemical & Pharmaceutical Bulletin
|
May 24, 2000
Polyphenols from Eriobotrya japonica and their cytotoxicity against human oral tumor cell lines
H Ito, E Kobayashi, Y Takamatsu, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
Y Nasu, C H Bangma, G W Hull, et al.
Gene Therapy
|
August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
Y Nasu, C H Bangma, G W Hull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines
G W Hull, M A Mccurdy, Y Nasu, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
Y Kita, T Hara, T Kawahara, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 160) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 160 results.
Nucleic Acids Research
|
July 25, 2000
The mouse L-histidine decarboxylase gene: structure and transcriptional regulation by CpG methylation in the promoter region
S Suzuki-Ishigaki, K Numayama-Tsuruta, A Kuramasu, et al.
Acta Paediatrica Japonica : Overseas Edition
|
August 8, 1998
Evaluation of left ventricular volume using automatic border detection in children: a comparison with conventional off-line echocardiographic quantification
I Hashimoto, F Ichida, M Miura, et al.
Prostate Cancer and Prostatic Diseases
|
March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters
S Ebara, S Shimura, Y Nasu, et al.
Clinical and Experimental Immunology
|
December 22, 1999
Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders
T Wada, K Takei, M Kudo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter
C Pramudji, S Shimura, S Ebara, et al.
Chemical & Pharmaceutical Bulletin
|
May 24, 2000
Polyphenols from Eriobotrya japonica and their cytotoxicity against human oral tumor cell lines
H Ito, E Kobayashi, Y Takamatsu, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
Y Nasu, C H Bangma, G W Hull, et al.
Gene Therapy
|
August 6, 1999
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
Y Nasu, C H Bangma, G W Hull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines
G W Hull, M A Mccurdy, Y Nasu, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
Y Kita, T Hara, T Kawahara, et al.
Page
of 16